title: In vitro metabolic transformations of 2,4-dipyrrolidinylpyrimidine: a chemical probe for P450-mediated oxidation of tirilazad mesylate.
abstract: 1. We have determined that 2,4-dipyrrolidinylpyrimidine (2,4-DPP), used as a model for studies of the metabolism of therapeutic agents containing this moiety, undergoes three characteristic hydroxylations when incubated with male rat liver microsomes. Analysis of microsomal incubates of stable isotope labelled analogues of 2,4-DPP by particle beam-liquid chromatography-mass spectrometry (LC-PB-MS) has shown that the three metabolites are 4-(3-hydroxypyrrolidinyl)-2-(pyrrolidinyl)-pyrimidine (M1), 4-(2-hydroxypyrrolidinyl)-2-(pyrrolidinyl)-pyrimidine (M2) and 2-(2-hydroxypyrrolidinyl)-4-(pyrrolidinyl)-pyrimidine (M3). 2. We determined that enzymes of the cytochrome P450 family are responsible for the in vitro hydroxylations of 2,4-DPP. 3. We observed that in microsomal incubations carried out in the presence of cyanide, a single cyanide adduct is formed implicating an iminium ion intermediate in the oxidation of the 2-pyrrolidine ring. 4. We also determined the intermolecular deuterium isotope effects for the formation of each of the three products. For M1, kH/kD = 14.55 +/- 0.54; for M2, kH/kD = 6.01 +/- 0.65; and for M3, kH/kD = 5.35 +/- 1.18. 5. We interpret these data as suggesting that M2 and M3 are formed by the same mechanism, probably including the formation of an iminium ion, and that M1 is formed by direct hydrogen abstraction.
authors.affiliation: Pharmacia and Upjohn, Inc., Kalamazoo, MI 49001, USA.
authors.forename: R T
authors.initials: RT
authors.lastname: Streeper
authors.forename: P G
authors.initials: PG
authors.lastname: Pearson
authors.forename: Z
authors.initials: Z
authors.lastname: Zhao
authors.forename: S A
authors.initials: SA
authors.lastname: Mizsak
authors.forename: P E
authors.initials: PE
authors.lastname: Sanders
authors.forename: L C
authors.initials: LC
authors.lastname: Wienkers
authors.forename: J J
authors.initials: JJ
authors.lastname: Vrbanac
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D001711:Biotransformation; D002853:Chromatography, Liquid; D003486:Cyanides / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003903:Deuterium; D016166:Free Radical Scavengers; D006900:Hydroxylation; D008297:Male; D013058:Mass Spectrometry; D010084:Oxidation-Reduction; D011281:Pregnatrienes / Q000378:metabolism* / Q000493:pharmacokinetics; D011743:Pyrimidines / Q000378:metabolism*; D011758:Pyrroles / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: C109884:2,4-dipyrrolidinylpyrimidine; D000975:Antioxidants; D003486:Cyanides; D016166:Free Radical Scavengers; D011281:Pregnatrienes; D011743:Pyrimidines; D011758:Pyrroles; D003577:Cytochrome P-450 Enzyme System; D003903:Deuterium; C053355:tirilazad